Stephen Ward, MD, PhD

Clinical Focus

• Adenomas
• Amyloidosis
• Autoimmune Hepatitis
• Bile Duct Diseases
• Biopsy
• Cholangiocarcinoma
• Cirrhosis
• Colon Polyps
• Colorectal Cancer

Show More

• Adenomas
• Amyloidosis
• Autoimmune Hepatitis
• Bile Duct Diseases
• Biopsy
• Cholangiocarcinoma
• Cirrhosis
• Colon Polyps
• Colorectal Cancer
• Esophageal Cancer
• Fatty Liver Disease
• Hemangioma
• Hepatitis B
• Hepatitis C
• Hepatocellular Carcinoma
• IBD
• Kidney Transplantation
• Liver Cancer
• Liver Transplant
• Peptic Ulcer
• Small Bowel Resection
• Ulcerative Colitis

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:26

Article:66

Review Article:7

Comment/Debate:3

Letter:3

Editorial:1

Chapter:1

Recent Artifacts

• Further prognostic stratification of intestinal type of gastric adenocarcinoma by CDX2 expression pattern
• Radiological and pathological assessment with EOB-MRI after Y90 radiation lobectomy prior to liver resection for hepatocellular carcinoma
• Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery (Nature Medicine, (2022), 28, 4, (626-629), 10.1038/s41591-022-01681-x)
• Gallbladder Cancer: A Single-Institution 10-Year Experience—Analysis of Adenocarcinoma Subtypes and Tumors Arising from Intracholecystic Papillary Neoplasms
• Solitary Peutz-Jeghers Type Polyp of Jejunum with Gastric Fundic and Antral Gland Lining Mucosa: A Case Report and Review of Literature
• Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid–enhanced MRI Scans after Liver-directed Radiation Therapy
• Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
• Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
• Impact of pathological response after neoadjuvant chemotherapy on adjuvant therapy decisions and patient outcomes in gastrointestinal cancers
• Gastric and small bowel perforations secondary to mucormycosis and graft versus host disease in an allogeneic transplant host

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Ward during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.